TD Asset Management
ASMB icon

TD Asset Management’s Assembly Biosciences ASMB Stock Holding History

TD Asset Management’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,570
Closed -$310K – 1439
2020
Q3 		$310K Hold
1,570
– – ﹤0.01% 1311
2020
Q2 		$439K Hold
1,570
– – ﹤0.01% 1233
2020
Q1 		$279K Sell
1,570
-175
-10% -$37.5K ﹤0.01% 1279
2019
Q4 		$428K Buy
+1,745
New +$321K ﹤0.01% 1271
2018
Q4 		– Sell
-949
Closed -$423K – 1391
2018
Q3 		$423K Buy
949
+166
+21% +$77.8K ﹤0.01% 1328
2018
Q2 		$369K Buy
783
+133
+20% +$70.3K ﹤0.01% 1327
2018
Q1 		$383K Buy
+650
New +$403K ﹤0.01% 1243

Other funds holding ASMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

TD Asset Management's ASMB Position: Q4 2020 in Review

TD Asset Management sold out of Assembly Biosciences (ASMB) in Q4 2020, closing a stake of 1,570 shares — an estimated $310K sold.

TD Asset Management first reported a position in ASMB in Q1 2018 and held it in 7 quarters. The position peaked at $439K in Q2 2020. 109 funds tracked by Wall St. Rank hold ASMB as of Q4 2020.

  • TD Asset Management reported no remaining Assembly Biosciences position as of Q4 2020 after selling out during the quarter.
  • TD Asset Management sold 1,570 Assembly Biosciences shares in Q4 2020, an estimated $310K.
  • TD Asset Management first reported a position in Assembly Biosciences in Q1 2018 and held it in 7 quarters.
  • TD Asset Management's Assembly Biosciences position peaked at $439K in Q2 2020.
  • 109 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2020.

Based on TD Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.